AbbVie, Inc. (ABBV)
226.21
+3.14
(+1.41%)
USD |
NYSE |
Jun 09, 14:39
AbbVie SG&A Expense (Quarterly) : 3.578B for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 607.30M |
| Gilead Sciences, Inc. | 1.451B |
| Regeneron Pharmaceuticals, Inc. | 647.70M |
| Travere Therapeutics, Inc. | 105.07M |
| Amgen, Inc. | 1.602B |